A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01643408
Recruitment Status : Completed
First Posted : July 18, 2012
Last Update Posted : May 9, 2014
Information provided by (Responsible Party):
Jazz Pharmaceuticals